| P2093 | author name string | Mariana J Kaplan | |
| P2860 | cites work | Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study | Q24793945 |
| | Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis | Q24801010 |
| | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study | Q24812262 |
| | Cardiovascular risk factors in women with and without rheumatoid arthritis | Q28171426 |
| | The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 |
| | Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 |
| | Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population | Q28250514 |
| | Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 |
| | Inflammation in atherosclerosis | Q29547428 |
| | C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 |
| | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Cellular mechanisms of insulin resistance | Q29619549 |
| | Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis | Q30481778 |
| | Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) | Q31107094 |
| | Interferon alfa-2a therapy for life-threatening hemangiomas of infancy | Q33359336 |
| | Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis | Q33565333 |
| | Microalbuminuria in patients with rheumatoid arthritis | Q33567099 |
| | Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. | Q52277817 |
| | The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. | Q53014491 |
| | Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. | Q53249650 |
| | Psoriasis: a possible risk factor for development of coronary artery calcification. | Q53504190 |
| | No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. | Q53539905 |
| | Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. | Q54389817 |
| | A tale of two diseases: atherosclerosis and rheumatoid arthritis. | Q54448410 |
| | Systemic lupus erythematosus predicts increased left ventricular mass | Q57216497 |
| | Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus | Q57216969 |
| | Tumor necrosis factor receptor type II (exon 6) and interleukin-6 (−174) gene polymorphisms are not associated with family history but tumor necrosis factor receptor type II is associated with hypertension in patients with rheumatoid arthritis from | Q57819629 |
| | Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS) | Q58071481 |
| | Risk of Myocardial Infarction in Patients With Psoriasis | Q60711909 |
| | Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women | Q61040663 |
| | Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis | Q61711491 |
| | Surface Expression of Fractalkine Receptor (CX3CR1) on CD4+/CD28 T Cells in RA Patients and Correlation with Atherosclerotic Damage | Q61733681 |
| | Precocious intima-media thickening in patients with primary Sjögren's syndrome | Q62395171 |
| | Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 |
| | Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma | Q71252764 |
| | Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids | Q71815421 |
| | Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities | Q73090150 |
| | Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 |
| | Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus | Q73167867 |
| | Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis | Q73374692 |
| | Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis | Q73378860 |
| | The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis | Q73613525 |
| | Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 |
| | Etiopathogenesis of systemic lupus erythematosus | Q74206752 |
| | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 |
| | Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis | Q79433649 |
| | Echocardiographic and clinical abnormalities in patients with psoriasis | Q79761580 |
| | Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus | Q79794986 |
| | Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies | Q80171473 |
| | Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis | Q80234116 |
| | Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis | Q80442338 |
| | Defective vasculogenesis in systemic sclerosis | Q80457437 |
| | Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome | Q80725362 |
| | Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial | Q80784895 |
| | Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study | Q80791227 |
| | Rheumatoid arthritis and heart failure | Q80899861 |
| | Flow-mediated arterial dilation in primary antiphospholipid syndrome | Q81014753 |
| | Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis | Q81252239 |
| | Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis | Q81290300 |
| | Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease | Q81398632 |
| | Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus | Q81517370 |
| | Endothelial progenitor cells and colony-forming units in rheumatoid arthritis: association with clinical characteristics | Q81746759 |
| | Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 |
| | Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy | Q82734935 |
| | [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome] | Q83072400 |
| | Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events | Q83856413 |
| | Atherosclerosis is an inflammatory disease | Q33762068 |
| | Peroxisome proliferator-activated receptors in the cardiovascular system | Q33850995 |
| | Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 |
| | Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 |
| | High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study | Q34090034 |
| | Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis | Q34283776 |
| | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 |
| | Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. | Q34478064 |
| | Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Q34582722 |
| | Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis | Q34648366 |
| | Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 |
| | Update on vascular disease in systemic lupus erythematosus | Q35213861 |
| | Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus | Q35552185 |
| | Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis | Q35553035 |
| | Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Q35553700 |
| | Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s | Q35554980 |
| | Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis | Q35555996 |
| | Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 |
| | Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis | Q35638659 |
| | Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis | Q35638708 |
| | Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis | Q35752661 |
| | Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 |
| | Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis | Q36059617 |
| | Atherosclerosis in patients with autoimmune disorders | Q36173656 |
| | The molecular basis for oxidative stress-induced insulin resistance | Q36184182 |
| | 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus | Q36290168 |
| | Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors | Q36757042 |
| | Mycophenolate mofetil and atherosclerosis: results of animal and human studies. | Q36958317 |
| | Systemic lupus erythematosus and "lupus dyslipoproteinemia". | Q37055444 |
| | Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction | Q37060522 |
| | The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. | Q37074034 |
| | Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. | Q37129611 |
| | Cardiovascular involvement in systemic autoimmune diseases | Q37279502 |
| | The vulnerable and unstable atherosclerotic plaque | Q37286807 |
| | Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms | Q37371379 |
| | Is atherosclerosis a complication of long-term corticosteroid treatment? | Q39732969 |
| | Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages | Q40043923 |
| | The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis | Q40053146 |
| | Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis | Q40497949 |
| | Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 |
| | Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells | Q41940507 |
| | Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients | Q41943173 |
| | Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis | Q41951968 |
| | C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. | Q42460041 |
| | Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 |
| | Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis | Q43049221 |
| | Risk factors for cardiovascular disease in systemic lupus erythematosus | Q43767819 |
| | Brachial endothelial function is impaired in patients with systemic lupus erythematosus | Q43884850 |
| | The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis | Q43927214 |
| | Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. | Q44068950 |
| | Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis | Q44177928 |
| | Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 |
| | Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus | Q44226563 |
| | Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans | Q44608866 |
| | A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls | Q44768065 |
| | Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. | Q44859412 |
| | Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 |
| | Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis | Q45129989 |
| | Effect of glucocorticoids on the arteries in rheumatoid arthritis | Q45184227 |
| | Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis | Q45293503 |
| | Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function | Q45820728 |
| | Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis | Q46222728 |
| | Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? | Q46407214 |
| | Endothelial dysfunction in patients with primary Sjögren's syndrome | Q46555620 |
| | Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome? | Q46677340 |
| | Impaired endothelial function in patients with ankylosing spondylitis | Q46735541 |
| | Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. | Q46852341 |
| | Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus | Q46973423 |
| | Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events | Q46988581 |
| | De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes | Q47817253 |
| | Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis | Q48502988 |
| | Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 |
| | Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. | Q50925165 |
| | Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. | Q50969877 |
| | High prevalence of metabolic syndrome in patients with ankylosing spondylitis. | Q51491387 |
| | Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. | Q52094951 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| | cardiovascular disease | Q389735 |
| P304 | page(s) | 208-217 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Nature Reviews Rheumatology | Q2107227 |
| P1476 | title | Management of cardiovascular disease risk in chronic inflammatory disorders | |
| P478 | volume | 5 | |